UAE Enforces Stricter Oversight on Medical Product Advertising
The Emirates Drug Establishment (EDE) has officially rolled out new regulatory frameworks to tighten control over how medical products are promoted across the UAE. During a recent session of the Medical Product Advertising Customer Council, officials emphasized that all promotional materialâspanning traditional media, websites, and social platformsâmust receive formal approval from the EDE before public release. This mandate is designed to ensure that all health-related advertising is accurate, transparent, and completely free of misleading claims. Furthermore, the authorities have explicitly prohibited the use of social media influencers for the promotion or endorsement of medical products, reinforcing the necessity for rigorous compliance.
The council also highlighted that all advertisements must align strictly with approved product information, ensuring that potential risks and side effects are clearly communicated to the public. There is a strong focus on preventing content that might encourage self-diagnosis or the misuse of medications without professional medical supervision. By streamlining the application and licensing process, the EDE aims to make it easier for businesses to comply with these rules while maintaining high standards of public safety. Ultimately, these measures serve as a proactive step to protect consumers and ensure that medical marketing remains ethical, professional, and subject to consistent regulatory inspection.